Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
|
HPC BIOSCIENCES LIMITED Our Company was originally incorporated in New Delhi as 'HPC Biosciences Limited' on 29th January, 2002 under the Companies Act, 1956 vide certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi & Haryana. For further, please refer to the section titled 'Our History and Corporate Structure' beginning on page 77 of this Prospectus. Registered Office & Corporate Office: 6A, 40, Hanuman Road,
Connaught Place, New Delhi-110001; PROMOTERS OF THE COMPANY: MS. MADHU ANAND & MR. TARUN CHAUHAN BASIS OF ALLOTMENT PUBLIC ISSUE OF 45,00,000 EQUITY SHARES OF RS. 10/- EACH ('EQUITY SHARES') OF HPC BIOSCIENCES LIMITED ('HPCBL' OR THE 'COMPANY' OR THE 'ISSUER') FOR CASH AT A PRICE OF RS. 35/- PER SHARE (THE 'ISSUE PRICE'), AGGREGATING TO RS. 1575.00 LACS ('THE ISSUE'), OF WHICH, 2,32,000 EQUITY SHARES OF RS. 10 EACH WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKERS TO THE ISSUE (THE ' MARKET MAKER RESERVATION PORTION'). THE ISSUE LESS THE MARKET MAKER RESERVATION PORTION I.e. ISSUE OF 42,68,000 EQUITY SHARES OF RS. 10 EACH IS HEREINAFTER REFERRED TO AS THE 'NET ISSUE'. THE ISSUE AND THE NET ISSUE WILL CONSTITUTE 28.30% AND 26.84%, RESPECTIVELY OF THE POST ISSUE PAID UP EQUITY SHARE CAPITAL OF THE COMPANY. In terms of Prospectus dated 22nd February, 2013 and as per Regulation 43 (4) of SEBI (ICDR) Regulations, 2009 wherein a minimum of 50 % of the Net Offer to Public shall be initially made available to Retail Individual Investors as the case may be. The balance net offer of shares to the public shall be made available for allotment to a) individual applicants other than retail investors and b) other investors including corporate bodies / institutions irrespective of no. of shares applied for. The unsubscribed portion of the net offer to any one of the categories specified in (a) or (b) shall/may be made available for allocation in any other category, if so required. Explanation: for the purpose of Regulation 43 (4) of SEBI (ICDR) Regulations, 2009, if the retail individual investor is entitled to more than fifty percent, on proportionate basis, the retail individual investors shall be allocated that higher percentage. THE FACE VALUE OF THE EQUITY SHARES IS RS. 10/- EACH AND THE ISSUE PRICE IS RS. 35 EACH. THE ISSUE PRICE IS 3.5 (THREE & HALF) TIMES OF THE FACE VALUE. ISSUE OPENED ON 1ST MARCH, 2013 AND CLOSED ON 5TH MARCH, 2013. The Equity Shares offered through the Prospectus are proposed to be listed on the SME platform of BSE Limited ('BSE') in terms of the chapter XB of the SEBI (ICDR) Regulations, 2009 as amended from time to time, Company is not required to obtain an in-principle approval of the shares being offered in this Issue. However Company has received an approval letter dated 21 st February, 2013 from BSE for using its name in the offer document for listing of our Shares on the SME platform of BSE. The designated stock exchange is BSE Limited. All Applicants were allowed to participate in the Issue through APPLICATION SUPPORTED BY BLOCKED AMOUNT ('ASBA') process by providing the details of the respective bank accounts in which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the 'SCSBs'). SUBSCRIPTION DETAILS The Issue has received 574 applications for 49,04,000 Equity Shares (Including Market Maker Application of 2,32,000 Equity Shares) resulting 1.09 times subscription. After considering, cheque return cases of 11 applications of 44,000 Equity Shares, the Issue was subscribed 1.08 times. The details of the applications received in the Issue (before technical rejections) are as follows: Detail of the Applications Received (Before Technical Rejection & withdrawal of application):
The details of applications rejected by the Registrar on technical grounds (Including withdrawals) are detailed below:
Detail of the Applications Received (After Technical Rejection & withdrawal):
ALLOCATION: The Basis of Allotment was finalized In consultation with the Designated Stock Exchange - BSE Limited on 14th March, 2013. A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the Issue price of Rs. 35/- per Equity Share, was finalised in consultation with BSE. The category was subscribed by 1.00 times. The total number of shares allotted In this category Is 2,32,000 Equity shares In full out of reserved portion of 2,32,000 Equity Shares. B. Allocation to Retail Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Retail Individual Investors, at the Issue price of Rs. 35/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 0.80 times. Total number of shares allotted In this category Is 17,04,000 Equity Shares against reservation of 21,34,000 Shares. The balance 4,30,000 Shares has been added to Non Institutional category as spill over. The category wise basis of allotment Is as under.
C. Allocation to Non Retail Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Non Retail Investors, at the issue price of Rs. 35/- per Equity Share, was finalized in consultation with BSE. The category was subscribed by 1.25 times. Total number of shares allotted In this category is 26,24,000 Equity Shares including spill over of 4,30,000 Shares from retail individual Investors category and additional 60,000 Equity Shares for the purpose of rounding off to the nearest multiple of 4,000 Equity Shares (Lot Size). The category wise basis of allotment is as under:
The Board of Directors of the Company at its meeting held on 14th
March, 2013 has taken on record the Basis of Allocation of Equity Shares approved by the
Designated Stock Exchange viz. BSE and has authorized the corporate action for the
transfer of the Equity Shares / dispatch of share certificates to various successful
applicants. INVESTORS PLEASE NOTE The details of the allotment made would also be hosted on the website of the Registrar to the Issue, Cameo Corporate Services Limited at www.cameoindia.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below: CAMEO CORPORATE SERVICES LTD. Subramanian Building, 1 Club House Road, For HPC Biosciences Limited Place : New Delhi |
The IPO allocation is based on the subscription level and the investor category.
Refer to IPO allotment rules and methods for more details.
See the basis of allotment document above to know how the shares are allocated in HPC Biosciences IPO .
The HPC Biosciences IPO basis of allotment (published above) tells you how shares are allocated to you in HPC Biosciences IPO and category wise demand of IPO share.
Visit the HPC Biosciences IPO allotment status page to check the number of shares allocated to your application.
In HPC Biosciences IPO allotment process, the registrar separates valid and invalid applications. The invalid applications with technical errors are rejected and only valid applications at or above the cut-off price are considered for allotment.
For more information, please refer to IPO Allotment Process and Basis of Allotment.
Check the HPC Biosciences IPO basis of allotment document to know how the shares are allocated in HPC Biosciences IPO.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
